Prof Barkhof said of the results; “Assessing the effect of MS treatments to prevent lesions evolving into so-called “Black Holes” is a relatively new manner to determine neuroprotection in MS. Reducing black holes signifies preservation of brain tissue and the slowing of MS disease progression. The positive
effects observed with ATL1102 on black holes are encouraging and suggestive of ATL1102’s potential neuroprotective effects, which could be very important, particularly when contemplating the drug’s
potential as a treatment for progressive forms of MS”.
ANP Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
